20 LATEST RESOURCES (144 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study · January 2024
Articles
Journal of Clinical Medicine
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature · January 2024
Articles
Journal of Clinical Medicine
Effectiveness of Vortioxetine for Winter Depression in Bipolar Disorder: A Case Report · January 2024
Articles
Psychiatry and Clinical Neurosciences Reports
Potential Effect of Vortioxetine on Restless Leg Syndrome · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder and Early-Stage Dementia: The MEMORY Study · June 2023
Articles
Journal of Affective Disorders
Clinical Benefits of Vortioxetine 20 Mg/Day in Patients with Major Depressive Disorder · April 2023
Articles
CNS Spectrums
Long-Term Safety and Efficacy, Including Anhedonia, of Vortioxetine for Major Depressive Disorder: Findings from Two Open-Label Studies · March 2023
Articles
Current Medical Research and Opinion
Safety and Effectiveness of Vortioxetine for Major Depressive Disorder: Real-World Evidence from a Population-Based Study in South Korea · March 2023
Articles
Frontiers in Psychiatry
Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-Blinded 6-Week Clinical Trial · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
Vortioxetine in Patients with Major Depressive Disorder and High Levels of Anxiety Symptoms: An Updated Analysis of Efficacy and Tolerability · January 2023
Articles
Journal of Affective Disorders
Effectiveness of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: US Cohort Results from the Global RELIEVE Study · January 2023
Articles
Frontiers in Psychiatry
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder and Co-Morbid Generalized Anxiety Disorder in Routine Clinical Practice: A Subgroup Analysis of the RELIEVE Study · November 2022
Articles
Journal of Psychopharmacology
Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism: In Vitro Study · November 2022
Articles
International Journal of Molecular Sciences
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study · October 2022
Articles
Brain Sciences
Central Monitoring of Depression and Anxiety Symptoms Reduces Placebo Responses in Depression Clinical Trials: A Post Hoc Exploratory Analysis of Data from the Phase III CCT-004 Trial of Vortioxetine · September 2022
Articles
Neuropsychopharmacology Reports
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study · August 2022
Articles
Neuropsychiatric Disease and Treatment
Vortioxetine Modulates the Regional Signal in First-Episode Drug-Free Major Depressive Disorder at Rest · June 2022
Articles
Frontiers in Psychiatry
Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults · June 2022
Articles
Frontiers in Psychiatry
Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study · May 2022
Articles
Clinical Psychopharmacology and Neuroscience